myMatrixx Releases New Electronic Prescribing in Workers' Compensation Trend White Paper

While electronic prescribing has become the norm in group health care, the adoption rate within workers’ compensation has been slow. Phil Walls, Chief Clinical Officer, uncovers some of the barriers to adoption in workers’ compensation, the benefits of continued implementation and the advanced innovative opportunities e-prescribing can help us achieve: patient safety, convenience and value to payers. Along with insights from Surescripts and the Surescripts Network Alliance, we are able to see the positive impact it has had in group health and the ways it can help address long-stand issues and inefficiencies in this industry.
Learn more

On-Demand Webinar — How Advanced Automation and Decision Intelligence Can Transform Workflows in Workers' Comp

Advanced automation and decision intelligence tools have tremendous potential to streamline workflows and improve efficiency for claims professionals, eliminating pain points and freeing up the workforce to focus on patient engagement and better outcomes. Learn more from Mike Cirillo, President of myMatrixx, along with Paul King, Chief Client Officer and Cliff Belliveau, Chief Innovation Officer, in this one-hour Risk & Insurance webinar.
Learn more

Engage, Learn and Connect with myMatrixx at NWCDC 2022

myMatrixx is heading to the 2022 National Workers’ Compensation and Disability Conference (NWCDC) in Las Vegas at the Mandalay Bay Resort. Learn all the ways you can connect with us including attending our program sessions, visiting our new Innovation Studio and more!
Learn more
myMatrixx WCI 2022 Conference

Connect with myMatrixx at #WCI2022

myMatrixx is heading to the 2022 Workers' Compensation Institute (WCI) conference being hold at the Orlando World Center Marriott August 21 - 24. View all the ways you can connect with us while attending the conference!
Learn more
myMatrixx Demystifying Drug Pricing Workers' Comp

myMatrixx Releases Demystifying Drug Pricing in Workers’ Compensation White Paper (Part One)

When discussing the growing cost of drugs, we tend to frame the topic around name-brand versus generic drugs, with a view that despite the cost-saving opportunities of generics, overall spending on drugs continues to increase. However, segmenting the drug market into categories beyond purely brand versus generic drugs enables us to more accurately identify the major trends and drivers for drug prices in workers’ compensation.
Learn more